Surendra K. Sharma, Tamilarasu Kadhiravan, Prathap Tharyan
{"title":"Cochrane上下文:利福霉素与异烟肼在hiv阴性患者活动性结核病风险中预防结核病的比较","authors":"Surendra K. Sharma, Tamilarasu Kadhiravan, Prathap Tharyan","doi":"10.1002/ebch.1959","DOIUrl":null,"url":null,"abstract":"<p><b>Cochrane Review: Rifamycins (rifampicin, rifabutin, and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB</b> Sharma SK, Sharma A, Kadhiravan T, Tharyan P. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD007545. DOI: 10.1002/14651858.CD007545.pub2.</p><p>This companion piece to the review, “Rifamycins (rifampicin, rifabutin, and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB,” contains the following pieces:\n\n </p>","PeriodicalId":12162,"journal":{"name":"Evidence-based child health : a Cochrane review journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2014-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/ebch.1959","citationCount":"0","resultStr":"{\"title\":\"Cochrane in context: Rifamycins compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB\",\"authors\":\"Surendra K. Sharma, Tamilarasu Kadhiravan, Prathap Tharyan\",\"doi\":\"10.1002/ebch.1959\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><b>Cochrane Review: Rifamycins (rifampicin, rifabutin, and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB</b> Sharma SK, Sharma A, Kadhiravan T, Tharyan P. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD007545. DOI: 10.1002/14651858.CD007545.pub2.</p><p>This companion piece to the review, “Rifamycins (rifampicin, rifabutin, and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB,” contains the following pieces:\\n\\n </p>\",\"PeriodicalId\":12162,\"journal\":{\"name\":\"Evidence-based child health : a Cochrane review journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-03-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/ebch.1959\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidence-based child health : a Cochrane review journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/ebch.1959\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence-based child health : a Cochrane review journal","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ebch.1959","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
Cochrane综述:利福霉素(利福平、利福布汀和利福喷丁)与异烟肼在hiv阴性、有活动性结核病风险人群中预防结核病的效果比较Sharma SK, Sharma A, Kadhiravan T, Tharyan P.利福霉素(利福平、利福布汀和利福喷丁)与异烟肼在有活动性结核病风险的hiv阴性人群中预防结核病的效果比较。Cochrane Database of Systematic Reviews 2013，第7期。艺术。不。: CD007545。cd007545.pub2 DOI: 10.1002/14651858.。这篇综述的同伴文章“利福霉素(利福平、利福布汀和利福喷丁)与异烟肼在预防活动性结核病风险的hiv阴性人群中的结核病中的作用”包含以下内容:
Cochrane in context: Rifamycins compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB
Cochrane Review: Rifamycins (rifampicin, rifabutin, and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB Sharma SK, Sharma A, Kadhiravan T, Tharyan P. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD007545. DOI: 10.1002/14651858.CD007545.pub2.
This companion piece to the review, “Rifamycins (rifampicin, rifabutin, and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB,” contains the following pieces:
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
